-$4.8M
Value of Insider Transactions in the last 2 years

Sign up to access historical data

Sign up

Insider Transactions

Name Transaction Date Sold / Bought Shares Price Value
Kim Susan G.Sep 30, 2024Sell19,782$1.722$34,000
HENRY CHRISTIAN OSep 16, 2024Sell98,907$1.746$170,000
Eidel JeffAug 19, 2024Sell26,760$1.592$43,000
Van Oene MarkAug 16, 2024Sell38,011$1.662$63,000
Farmer MicheleMay 20, 2024Sell5,275$2.03$11,000
Meline David WMar 6, 2024Buy40,000$4.404$180,000
HENRY CHRISTIAN OMar 4, 2024Sell14,177$4.871$69,000
Farmer MicheleMar 4, 2024Sell2,968$4.871$14,000
Van Oene MarkMar 4, 2024Sell9,186$4.871$45,000
Kim Susan G.Mar 4, 2024Sell5,275$4.871$26,000
HENRY CHRISTIAN OFeb 20, 2024Sell1,979$5.261$10,000
Kim Susan G.Feb 20, 2024Sell831$5.261$4,400
Van Oene MarkFeb 16, 2024Sell33,560$5.958$200,000
Eidel JeffFeb 16, 2024Sell15,498$5.958$92,000
Kim Susan G.Feb 16, 2024Sell22,496$5.958$130,000
HENRY CHRISTIAN OFeb 16, 2024Sell79,038$5.958$470,000
Farmer MicheleFeb 16, 2024Sell7,562$5.958$45,000
Van Oene MarkJan 9, 2024Sell31,012$7.773$240,000
HENRY CHRISTIAN ODec 14, 2023Sell20,000$10$200,000
Kim Susan G.Sep 29, 2023Sell19,257$8.437$160,000
HENRY CHRISTIAN OSep 18, 2023Sell96,844$10.122$980,000
HENRY CHRISTIAN OSep 11, 2023Sell10,000$10.452$100,000
HENRY CHRISTIAN OAug 17, 2023Sell10,000$10.5$110,000
Eidel JeffAug 17, 2023Sell25,936$10.597$270,000
Van Oene MarkAug 16, 2023Sell26,102$11$290,000
Farmer MicheleMay 18, 2023Sell5,165$12.59$65,000
Ericson William W.Mar 15, 2023Sell7,541$8.9$67,000
HENRY CHRISTIAN OMar 3, 2023Sell13,769$9.493$130,000
Van Oene MarkMar 3, 2023Sell6,268$9.493$60,000
Kim Susan G.Mar 3, 2023Sell5,045$9.493$48,000
Farmer MicheleMar 3, 2023Sell3,153$9.493$30,000
HENRY CHRISTIAN OFeb 17, 2023Sell1,530$10.271$16,000
Kim Susan G.Feb 17, 2023Sell907$10.271$9,300
Van Oene MarkJan 10, 2023Sell26,722$9.534$250,000
HENRY CHRISTIAN ODec 1, 2022Sell45,000$10.844$490,000

What's the latest insider transaction for Pacific Biosciences of California?

The most recent insider transaction for Pacific Biosciences of California was conducted by Kim Susan G., who sold 19,782 shares on September 30, 2024 at a price of $1.72 per share.

Which insider bought the most PACB stock over the last two years?

Meline David W has bought the most PACB stock in the last 2 years, with a total value of $180,000.

Which insider has sold the most PACB stock over the last two years?

HENRY CHRISTIAN O has sold the most PACB stock in the last 2 years, with a total value of $2.7M.

What is the total value of insider transactions for Pacific Biosciences of California (PACB) in the last 2 years?

The total value of insider transactions for Pacific Biosciences of California in the last 2 years is negative, amounting to -$4.8M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.

How do insider transactions over the last 2 years reflect on Pacific Biosciences of California's market confidence?

Over the last 2 years, insider transactions for Pacific Biosciences of California have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.

Why is monitoring insider trading activity important for investors?

Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.